Abstract：
:Despite the clonal origin of most tumors, their tremendous heterogeneity suggests that cancer progression springs from the combined forces of both genetic and epigenetic events, which produce variant clonal populations, together with the selective pressures of the microenvironment, which promote growth and, perhaps, dissemination of variants with a specific set of characteristics. Although the importance of genetic mutations in cancer has long been recognized, the role of epigenetic events has been suggested more recently. This review focuses on the genetic and epigenetic molecular mechanisms involved in cancer onset and progression, and discusses the possibility of new strategies in the development of anticancer treatments.
journal_name
Oncogenejournal_title
Oncogeneauthors
Macaluso M,Paggi MG,Giordano Adoi
10.1038/sj.onc.1206955subject
Has Abstractpub_date
2003-09-29 00:00:00pages
6472-8issue
42eissn
0950-9232issn
1476-5594pii
1206955journal_volume
22pub_type
杂志文章,评审相关文献
ONCOGENE文献大全abstract：:The molecular interactions implicated in the mammalian G1/S cell cycle phase transition comprise a highly nonlinear network which can produce seemingly paradoxical results and make intuitive interpretations unreliable. A new approach to this problem is presented, consisting of (1) a convention of unambiguous reaction ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201608
更新日期：1998-02-26 00:00:00
abstract：:REF cells transformed by oncogenes E1A and cHa-ras reveal high and constitutive DNA-binding activity of AP-1 factor lacking in c-Fos protein. Consistently, the transcription of c-fos gene has been found to be downregulated. To elucidate the mechanisms of c-fos downregulation in E1A+cHa-ras transformants, we studied th...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1205118
更新日期：2002-01-24 00:00:00
abstract：:To date, a large number of long non-coding RNAs (lncRNAs) have been recently discovered through functional genomics studies. Importantly, lncRNAs have been shown, in many cases, to function as master regulators for gene expression and thus, they can play a critical role in various biological functions and disease proc...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/onc.2017.184
更新日期：2017-10-12 00:00:00
abstract：:Heregulins (neuregulins) are a family of proteins known to interact and activate the receptor tyrosine kinases ErbB2 in association with ErbB3 or ErbB4. Using immunofluorescence microscopy, electron microscopy autoradiography, and SDS-PAGE analysis of nuclear fractions, we show that the heregulin-beta1(1-244) isoform ...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-06-06 00:00:00
abstract：:Transcriptional coactivators SRC-1 and p300 specifically interact with liganded-nuclear receptors and also modulate other transcription factors, including serum response factor (SRF). Here, we report that retinoids repress transactivation by SRF and specific interactions exist between the DNA binding domains of SRF an...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204695
更新日期：2001-10-04 00:00:00
abstract：:Sequence-specific transcriptional regulators function by stably binding cognate DNA sequences followed by recruitment of both general and specialized factors to target gene promoters. The tumor suppressor p53 mediates its anti-oncogenic effect on cells by functioning as a sequence-specific regulator. p53 employs a sec...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210935
更新日期：2008-04-24 00:00:00
abstract：:Paxillin (PXN), a key component of the focal adhesion complex, has been associated with cancer progression, but the underlying mechanisms are poorly understood. The purpose of this study was to elucidate mechanisms by which PXN affects cancer growth and progression, which we addressed using cancer patient data, cell l...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/s41388-020-01517-3
更新日期：2021-01-01 00:00:00
abstract：:DDB2, a gene mutated in XPE patients, is involved in global genomic repair especially the repair of cyclobutane pyrimidine dimers (CPDs), and is regulated by p53 in human cells. We show that DDB2 is expressed in mouse tissues and demonstrate, using primary mouse epithelial cells, that mouse DDB2 is regulated by E2F tr...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210151
更新日期：2007-05-24 00:00:00
abstract：:Activating the protein-tyrosine kinase activity of v-Src rapidly induced expression of the two 'primary response' genes, TIS10 and Egr-1, in Balb/c 3T3 cells. Depleting cells of protein kinase C (PKC) by prolonged exposure to 12-O-tetradecanoylphorbol 13-acetate (TPA), blocked v-Src-induced TIS10 expression, but had n...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1991-06-01 00:00:00
abstract：:Brain-specific angiogenesis inhibitor 1 (BAI1), an orphan G protein-coupled receptor-type seven transmembrane protein, was recently found mutated or silenced in multiple human cancers and can interfere with tumor growth when overexpressed. Yet, little is known about its regulation and the molecular mechanisms through ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2012.1
更新日期：2012-12-13 00:00:00
abstract：:Glioblastoma multifome is the most common and most aggressive primary brain tumor with no current curative therapy. We found expression of the bZip transcription factor ATF5 in all 29 human glioblastomas and eight human and rat glioma cell lines assessed. ATF5 is not detectably expressed by mature brain neurons and as...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1209116
更新日期：2006-02-09 00:00:00
abstract：:Augmented reactive oxygen species levels consequential to functional alteration of key mitochondrial attributes contribute to carcinogenesis, either directly via oxidative DNA damage infliction or indirectly via activation of oncogenic signaling cascades. We previously reported activation of a key oncogenic signaling ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2016.346
更新日期：2017-03-30 00:00:00
abstract：:Prostate cancer (PCa) cell proliferation is dependent on activation of the androgen receptor (AR), a ligand-dependent transcription factor. AR activation controls G1-S phase progression through fostering enhanced translation of the D-type cyclins, which promote cell cycle progression through activation of CDK4/6. Howe...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210981
更新日期：2008-05-15 00:00:00
abstract：:Upregulation of acidic and basic fibroblast growth factors (FGF-1 and -2), and their cognate receptors FGFR-1 and -2, has been demonstrated in a variety of epithelial malignancies. However, the patterns of FGF/FGFR expression at specific stages of epithelial carcinogenesis have not been extensively characterized. In t...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-11-07 00:00:00
abstract：:Philadelphia chromosome (Ph)-positive leukaemia cells express the chimeric bcr/abl oncoprotein, whose deregulated protein tyrosine kinase (PTK) activity antagonizes the induction of apoptosis by DNA damaging agents. Treatment of Ph-positive K562, TOM 1 and KCL-22 cells with etoposide for 2d induced cytosolic vacuolati...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1201680
更新日期：1998-03-26 00:00:00
abstract：:Radiation therapy (RT) is useful for selectively killing cancer cells. However, because high levels of ionizing radiation (IR) are toxic to normal cells, RT cannot be applied repeatedly to cancer patients. Therefore, novel chemicals that enhance the efficacy of chemoradiotherapy (CRT) would be valuable. Here, we repor...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2015.47
更新日期：2015-12-03 00:00:00
abstract：:Embryonic stem (ES) cells have provided a valid model to understand early events of mammalian lineage specification and differentiation, leading to important insights into the mechanisms that control embryogenesis at the molecular and cellular levels. Furthermore, ES cells have recently evoked great scientific interes...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1208917
更新日期：2005-08-29 00:00:00
abstract：:EndoA is a type II keratin and with EndoB (type I keratin), constitutes intermediate filaments in various simple epithelial tissues. EndoA is developmentally regulated and has an enhancer that is located at the 3'- end of the gene. This enhancer contains two single and five dual Ets binding sites. Thus far, no other p...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-02-01 00:00:00
abstract：:Genetic suppression of the neoplastic phenotype has been demonstrated in somatic cell hybrids between tumor and normal cells. Suppression in whole-cell and microcell hybrids cannot, as yet, be attributed to specific elements defined at the molecular level. To identify a gene capable of suppressing the neoplastic pheno...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1991-12-01 00:00:00
abstract：:CDX2 is a Drosophila caudal-related homeobox transcription factor that is important for the establishment and maintenance of intestinal epithelial cells. CDX2 is a marker of colon cancer, with strong staining in up to 90% of colonic adenocarcinomas. CDX2 heterozygous-null mice develop colonic neoplasms, which have sug...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1209247
更新日期：2006-04-06 00:00:00
abstract：:Glypican-3 (GPC3) is a membrane-bound heparan sulfate proteoglycan that is mutated in the Simpson-Golabi-Behmel syndrome. This is an X-linked condition characterized by overgrowth, and various visceral and skeletal dysmorphisms. The phenotype of the Simpson-Golabi-Behmel syndrome patients and GPC3-deficient mice, as w...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1204925
更新日期：2001-11-01 00:00:00
abstract：:Synemin (SYNM) is a type IV intermediate filament that has recently been shown to interact with the LIM domain protein zyxin, thereby possibly modulating cell adhesion and cell motility. Owing to this multiplicity of potential functions relevant to cancer development, we initiated a study to decipher SYNM expression a...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2010.229
更新日期：2010-08-26 00:00:00
abstract：:Tumor suppressor TP53 is frequently mutated in colorectal cancer (CRC), and most mutations are missense type. Although gain-of-functions by mutant p53 have been demonstrated experimentally, the precise mechanism for malignant progression in in vivo tumors remains unsolved. We generated ApcΔ716 Trp53LSL•R270H villin-Cr...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2017.194
更新日期：2017-10-19 00:00:00
abstract：:Caspase-8 is a key effector of death-receptor-triggered apoptosis. In a previous study, we demonstrated, however, that caspase-8 can also be activated in a death receptor-independent manner via the mitochondrial apoptosis pathway, downstream of caspase-3. Here, we show that caspases-3 and -8 mediate a mitochondrial am...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206280
更新日期：2003-04-17 00:00:00
abstract：:VEGFR-1 (Flt-1), VEGFR-2 (KDR) and VEGFR-3 (Flt4) are endothelial specific receptor tyrosine kinases, regulated by members of the vascular endothelial growth factor family. VEGFRs are indispensable for embryonic vascular development, and are involved in the regulation of many aspects of physiological and pathological ...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1203855
更新日期：2000-11-20 00:00:00
abstract：:The intrinsic mitochondrial apoptotic pathway acts through two core pro-apoptotic proteins Bax (Bcl2-associated X protein) and Bak (Bcl2-antagonist/killer 1). Although Bax and Bak seem to have redundant roles in apoptosis, accumulating evidence also suggests that they might not be interchangeable under certain conditi...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2011.497
更新日期：2012-06-28 00:00:00
abstract：:Colorectal cancer is a major cause of cancer deaths in Western countries, but epidemiological data suggest that dietary modification might reduce these by as much as 90%. Cyclo-oxygenase 2 (COX2), an inducible isoform of prostaglandin H synthase, which mediates prostaglandin synthesis during inflammation, and which is...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202980
更新日期：1999-10-28 00:00:00
abstract：:MicroRNAs (miRNAs) make up a novel class of gene regulators; they function as oncogenes or tumor suppressors by targeting tumor-suppressor genes or oncogenes. A recent study that analysed a large number of human cancer cell lines showed that miR-330 is a potential tumor-suppressor gene. However, the function and molec...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2009.192
更新日期：2009-09-24 00:00:00
abstract：:The cellular response to DNA damage is a crucial surveillance mechanism that maintains genomic integrity and prevents cancer progression. Previous studies identified multiple Ser/Thr protein kinases that have pivotal roles in the activation of this response. It is interesting that a growing body of evidence suggests t...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/onc.2010.371
更新日期：2010-11-11 00:00:00
abstract：:The Wilms' tumor suppressor gene, WT1, functions as a transcriptional regulator that represses or activates the expression of a variety of putative target genes. However, it is not clear which genes are the biological targets of WT1, nor which cellular pathway(s) is critically altered in tumors as a result of WT1 muta...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206597
更新日期：2003-06-12 00:00:00
